In essence, the court of first instance granted a refund to a pharmaceutical company based on the CJEU Boehringer case (C-462/16) although the pharmaceutical company was not obliged to grant the rebates under national law.
Source: michaelamerz.org
See also
Latest Posts in "Netherlands"
- VAT on Free Social Media Access Still Uncertain Amid Ongoing EU Discussions
- New DAC7 Portal for Reporting Platform Seller Data Available from February 2026
- BBB Criticizes ‘Tulip Tax’: Higher VAT on Floriculture Threatens Jobs and Affordability
- Netherlands Delays VAT on ‘Free’ Social Media Services Amid European Debate and Legal Uncertainty
- Parliamentary Questions on VAT for Social Media: Response to FD Article and European Developments
